Adverse events with fatal outcome associated with alemtuzumab treatment in multiple sclerosis
Abstract Objective Sporadic fatal adverse events have been reported during treatment of multiple sclerosis with alemtuzumab. To provide a systematic overview, we searched the centralized European Medicines Agency database of suspected adverse reactions related to medicinal products (EudraVigilance)...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BMC
2019-08-01
|
| 叢編: | BMC Research Notes |
| 主題: | |
| 在線閱讀: | http://link.springer.com/article/10.1186/s13104-019-4507-6 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|